Stratton Management’s Novartis NVS Stock Holding History

Stratton Management’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	$845K	Sell	10,962 -224	-2%	-$17.8K	0.1%	155
2015 Q3	$921K	Buy	11,186 +5,921	+112%	+$527K	0.11%	151
2015 Q2	$464K	Hold	5,265	–	–	0.02%	279
2015 Q1	$465K	Buy	5,265 +50	+1%	+$4.43K	0.02%	295
2014 Q4	$433K	Buy	5,215 +2,146	+70%	+$178K	0.02%	298
2014 Q3	$259K	Sell	3,069 -2,037	-40%	-$165K	0.01%	308
2014 Q2	$414K	Buy	5,106 +335	+7%	+$26.3K	0.02%	301
2014 Q1	$363K	Hold	4,771	–	–	0.02%	300
2013 Q4	$344K	Buy	4,771 +558	+13%	+$38.8K	0.02%	306
2013 Q3	$290K	Buy	+4,213	New	+$279K	0.02%	315

Other funds holding NVS

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

BBHC

Brown Brothers Harriman & Co New York $22.8B AUM 25.09% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Institutional Capital Chicago, Illinois $6.75B AUM 3.51% 1-Year Est. Return

Stratton Management's NVS Position: Q4 2015 in Review

Stratton Management reduced its Novartis (NVS) stake by 2% in Q4 2015, selling an estimated $17.8K and leaving 10,962 shares worth $845K. The position accounts for 0.1% of the portfolio, ranked #155.

Stratton Management first reported a position in NVS in Q3 2013 and has held it in 10 quarters since. The position peaked at $921K in Q3 2015. 927 funds tracked by Wall St. Rank hold NVS as of Q4 2015.

Stratton Management held 10,962 shares of Novartis worth $845K as of Q4 2015.
Stratton Management sold 224 Novartis shares in Q4 2015, an estimated $17.8K.
Novartis made up 0.1% of Stratton Management's portfolio in Q4 2015, its #155 holding.
Stratton Management first reported a position in Novartis in Q3 2013 and has held it in 10 quarters since.
Stratton Management's Novartis position peaked at $921K in Q3 2015.
927 funds tracked by Wall St. Rank held Novartis as of Q4 2015.

Based on Stratton Management's 13F filing for Q4 2015, filed 11 Feb 2016.